Summary. Lipodystrophic diabetes mellitus of the Seip-Berardinelli type is a syndrome associated with insulin resistance and recessive inheritance. We have examined whether mutations in the insulin receptor are pathogenetic factors in this syndrome. Fibroblasts from three different patients with Seip-Berardinelli's lipodystrophy were tested for insulin binding, and insulin-stimulated receptor autophosphorylation. In addition, the coding region of both alleles of the insulin receptor gene was sequenced. No abnormalities in the number of high affinity insulin binding sites, and insulinstimulated receptor autophosphorylation were detected. The insulin receptor related insulin-like growth factor I receptor also showed no functional changes. DNA sequence analysis of the amplified exons of the insulin receptor gene showed a silent mutation in patient i at codon Ser 339, changing AGT to AGC. In patient 2 a heterozygous Met for Val substitution at position 985 was detected, which is a rare polymorphism. In patient 3 no mutations, other than described polymorphisms, were observed. These findings demonstrate that the primary genetic lesion in Seip-Berardinelli's lipodystrophy is outside the insulin receptor gene and that an involvement of the insulin-like growth factor I receptor is also unlikely.
Insulin resistance is a characteristic of several inborn syndromes. In some of these, genetic factors contribute to the pathogenesis of the disease. Insulin resistance can originate from mutations in the insulin receptor (IR) gene or from mutations in post-receptor components which are involved in expressing insulin action.
Mutations in the genes for glucokinase [1] and mitochondrial DNA [2] are examples of post-receptor defects found in a few particular families with maturity-onset diabetes of the young and Type 2 (non-insulin-dependent) diabetes mellitus. On the other hand, a large number of mutations in the IR have been detected in patients with a variety of insulin resistance syndromes, such as leprechaunism, type A insulin resistance and the RabsonMendenhall syndrome [3] . Especially intriguing are those IR mutations which cause aberrant signalling, affecting only a subset of biological responses of insulin and leaving other responses almost normal [4] .
Most cells express, in addition to the IR, also the related receptors for insulin-like growth factor I (IGF-I) which can activate similar signalling pathways as the IR and it is conceivable that these receptors may contribute to correct in vivo insulin action. Particular characteristics of Seip-Berardinelli's lipodystrophy (SBLD) are insulin resistant diabetes, growth anomalies, acanthosis nigricans, genital hypertrophy, hepatomegaly and hirsutism, symptoms frequently seen in patients with IR mutations. An additional feature of this syndrome is that the anabolic action of insulin on fat is predominantly affected. The anabolic action on protein appears unchanged, as concluded from the muscular hypertrophy resulting in the typical "herculean" aspect of these patients. As such a situation can result from mutations in the IR causing discordant signalling, we have examined the function and structure of the IR in fibroblasts from three unrelated patients with SBLD. All the patients were born from consanguineous marriages. The fibroblasts were tested for IR mRNA expression, insulin binding and insulin-stimulated autophosphorylation of the IR. In addition, the sequence of the coding region of the IR was determined. The possible involvement of an altered IGF-I receptor function in the pathogenesis of SBLD was examined through IGF, I binding and IGF-I stimulated autophosphorylation of the IGF-I receptor. 
Materials and methods

Materials
Fibroblasts of three children with the clinical diagnosis of SBLD were investigated. All the patients were from consanguineous marriages and showed characteristics of SBLD such as lack of subcutaneous fat, hyperlipidaemia and hepatomegaly. Patient 1, a Caucasian female, 15 years old, had fasting hyperinsulinaemia (215 mU/1), glucosuria and acanthosis nigricans. Patient 2, a mediterranean female, 13 years old, was overtly diabetic, also had glucosuria and received 5 U-kg -1. day -~ insulin i.m.. Patient 3, a mediterranean male, 2 years old, was normoglycaemic with fasting hyperinsulinaemia (34 mU/1) and showed accelerated growth. 
Discussion
Methods"
Conditions for fibroblast culture, mRNA isolation, Northern blot analysis, binding of insulin and IGF-I, receptor autophosphorylation and direct sequencing of amplified IR-exons have been described [5] . The codon numbering is according to Ebina et al. [6] Results N o r t h e r n blot analysis of I R m R N A in total R N A from fibroblasts of all t h r e e patients showed a n o r m a l level of expression and no d e t e c t a b l e change in the size of the various I R m R N A s . Also, the n u m b e r of high affinity binding sites for insulin and I G F -I was not decreased. R e m a r k a b l y the insulin binding in p a t i e n t 2 was 0.35 + 0.03 fmol/106 fibroblasts (control subjects: 0.12-0.22 fmol/106). B o t h receptors s h o w e d a n o r m a l increase in l i g a n d
-i n d u c e d autop h o s p h o r y l a t i o n of the r e c e p t o r fl-subunits (Fig. 1). D i r e c t sequencing of D N A isolated from the fibroblasts d e m o n s t r a t e d in p a t i e n t 1 a silent, h e t e r o z y g o u s m u t a t i o n at Ser 339, changing A G T into A G C . Patient 2
was h e t e r o z y g o u s for the rare M e t 9s5 variant and p a t i e n t 3 showed a n o r m a l I R gene s e q u e n c e with only the pub- Although no functional defects of the IR could be detected, the possibility still existed that mutations were present which did not affect insulin binding or IR autophosphorylation but rather coupling of the activated re X ceptor with specific signalling pathways. A mutation of this kind has been described in the t-chain of the IR by Moller et al. [4] in a patient with type A insulin resistance.
To examine this possibility we sequenced the coding region of the IR gene of the three patients. In patient I we found a silent mutation at position 339, changing AGT into AGC. Patient 2 was heterozygous for the Met 985 mutation. This mutation was initially detected in a patient with Type 2 diabetes, but a recent report by O'Rahilly et al. [9] indicated that it occurred both in diabetic and non-diabetic subjects, suggesting that it is a polymorphism. Except for these two polymorphisms, no alterations in the IR gene were seen other than the polymorphisms described by Ebina et al. [6] and Ullrich et a1. [10] . Furthermore, we expected a homozygous gene defect in the patients because of consanguinity of their parents. The heterozygosity for some polymorphisms of the IR gene argues against the involvement of IR defects.
In conclusion, we found no IR defect in three patients with Seip-Berardinelli's lipodystrophy and also IGF-I receptor functions were normal. Thus, the inability of insulin to stimulate the anabolic action on fat in these patients seems to result from a post-receptor lesion. This defect can reside in enzymatic pathways for lipid metabolism or in factors regulating the growth and proliferation of adipocytes. E. R. van der Vorm et al.: Insulin receptor structure in lipodystrophy
